Welcome, Guest. Please login or register.
February 21, 2020, 04:35:47 pm

Login with username, password and session length


Members
Stats
  • Total Posts: 54759
  • Total Topics: 4710
  • Online Today: 159
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 1
Guests: 146
Total: 147

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Injection Drug Users Are Increasingly Using Syringe Services Programs  (Read 2572 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 692
    • Hep Mag
Use of syringe services programs (SSPs), which provide an array of harm reduction services, has risen considerably among injection drug users (IDUs) over the past decade. However, a worrisome proportion of IDUs still share needles with others, putting them at risk of HIV and hepatitis C virus (HCV) transmission.

“Until now, the nation has made substantial progress in preventing HIV among people who inject drugs, but this success is threatened,” said Jonathan Mermin, MD, MPH, director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. “Syringe services programs work, and their expansion is pivotal for progress in the coming decades.”

The Centers for Disease Control and Prevention (CDC) conducted a study of SSP use based on National HIV Behavioral Surveillance interviews of IDUs in 22 U.S. cities with a high HIV prevalence. The report also factored in National HIV Surveillance System data on HIV infection trends.

For more...
https://www.hepmag.com/article/injection-drug-users-increasingly-using-syringe-services-programs

 


© 2020 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.